Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
IL-1β Tetrapeptide Sequence Regulates Inflammatory Caspase A
2026-06-12
This study reveals that the P4-P1 tetrapeptide sequence of IL-1β is a key determinant for its selective recruitment and activation by inflammatory caspases, influencing the generation of bioactive cytokine species. These mechanistic insights refine our understanding of inflammasome signaling and have practical implications for disease models targeting IL-1β and IL-18 processing.
-
Recombinant Human Oncostatin M: Mechanisms & Research Use
2026-06-11
Recombinant Human Oncostatin M (rh-Oncostatin M) is a biologically active, tag-free cytokine used for cell proliferation and cytokine induction studies. This product, produced in E.coli and lyophilized for stability, provides high purity and reproducibility in research models. Its precise activity profile enables robust, evidence-backed workflow integration.
-
Trichostatin A (TSA): Protocols for Epigenetic and Cancer Re
2026-06-11
Trichostatin A (TSA) is a well-characterized HDAC inhibitor used to study epigenetic regulation, cancer cell proliferation, and cell cycle control. Researchers rely on TSA for precise, reproducible modulation of histone acetylation in cell and animal models. TSA is not recommended for use in workflows requiring aqueous solubility or extended solution stability.
-
Isoprinosine: Mechanisms and Evidence for Antiviral Immunoth
2026-06-10
Isoprinosine (inosine pranobex) is a multi-component immunomodulatory agent with proven efficacy against acute respiratory viral infections and inhibition of HHV-1 replication. Its mechanism involves direct antiviral effects as well as enhancement of immune cell responses, with performance validated in vivo and in clinical trials. This article clarifies molecular mechanisms, use-case boundaries, and protocol parameters for research and clinical applications.
-
Poly(I:C): Beyond TLR3 Agonism—New Frontiers in Immune Modul
2026-06-10
Explore Poly(I:C), a synthetic double-stranded RNA analog, as more than a TLR3 agonist—delve into its unique role in neuroimmune regulation, assay design, and advanced immunology research, with practical insights for experimental optimization.
-
Baicalin Methyl Ester: Mechanistic Precision in Gut Barrier
2026-06-09
This article explores how baicalin methyl ester, a leading esterified derivative of baicalin, is redefining the mechanistic landscape of LPS-induced intestinal barrier damage research. Integrating rigorous experimental evidence, competitive positioning, and translational strategy, it provides researchers with actionable guidance and future-facing insights, while highlighting APExBIO’s BME as a foundational tool.
-
Pterostilbene Enhances Mitophagy to Delay Fibroblast Senesce
2026-06-09
Zhou et al. (2025) demonstrate that pterostilbene delays senescence in human dermal fibroblasts by promoting mitochondrial quality control through enhanced mitophagy. These findings clarify the cellular mechanisms of dermal aging and provide a robust platform for anti-aging research targeting mitochondrial function.
-
EdU Imaging Kits (HF488): Elevating Quantitative Cell Prolif
2026-06-08
Unlock advanced cell proliferation analysis with EdU Imaging Kits (HF488), leveraging 5-ethynyl-2'-deoxyuridine and click chemistry for precise DNA synthesis measurement. This article uniquely explores how assay sensitivity, workflow optimization, and multi-omics integration drive modern biomarker and therapeutic discovery.
-
Prestained Protein Marker (Triple color, EDTA free, 10-250 k
2026-06-08
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses the need for reliable, visually distinct molecular weight standards in SDS-PAGE and Western blot assays, especially where EDTA-free formulation and compatibility with fluorescent imaging or phosphoprotein analysis are critical. It should not be used for direct protein quantification or substituted for unstained markers in precise migration studies.
-
Hybridization and Pluripotency Network Rewiring in Xenopus l
2026-06-07
This study dissects how evolutionary hybridization in Xenopus laevis caused extensive rewiring of the pluripotency gene regulatory network. By integrating chromatin profiling and transcriptional analysis, the authors reveal asymmetric genome activation between subgenomes, highlighting both regulatory divergence and conservation of core gene dosage. These findings illuminate how polyploidy can reshape gene control in early vertebrate development.
-
Pam3CSK4 TFA: Precision Tools to Decipher TLR1/2-Driven Immu
2026-06-06
This thought-leadership article explores how Pam3CSK4 TFA empowers translational researchers to unravel the mechanistic underpinnings of TLR1/2-mediated immune responses, with a focus on maternal-neonatal infection risk and cytokine biomarker discovery. By integrating recent clinical findings on IL-17A and leveraging the unique product attributes of APExBIO's Pam3CSK4 TFA, the article offers strategic, actionable insight for those designing robust in vitro and in vivo immunity studies.
-
Mapping Mutational Drivers in Myeloma Cell Lines: Implicatio
2026-06-05
This article reviews a landmark exome sequencing study of 30 human multiple myeloma cell lines, identifying recurrent mutations and altered pathways linked to disease progression and therapy resistance. The findings refine model selection for hematological malignancy research and inform targeted experimental design, especially for studies investigating drug responses and tumor microenvironment modulation.
-
NBC19: Advanced NLRP3 Inflammasome Inhibitor Workflows
2026-06-05
NBC19 stands out as a nanomolar-potency NLRP3 inflammasome inhibitor, enabling highly reproducible suppression of IL-1β release in both Nigericin- and ATP-induced models. Its robust performance and workflow flexibility make NBC19 an essential tool for dissecting inflammatory signaling and metastatic niche formation in translational research.
-
Isoprinosine in Viral Immunotherapy: Protocols, Innovations
2026-06-04
Isoprinosine (inosine pranobex) uniquely bridges immunomodulation with viral egress inhibition, empowering the next generation of antiviral assay design. This guide delivers actionable protocol enhancements, troubleshooting insights, and evidence-based workflow strategies for researchers targeting acute respiratory and herpesvirus infections.
-
Optimizing CAR-T Cell Tonic Signaling via Charge Density Tun
2026-06-04
This study uncovers how positively charged patches on chimeric antigen receptors (CARs) drive their clustering and induce tonic signaling, impacting CAR-T cell persistence and antitumor efficacy. Rational modification of CAR surface charge offers a promising strategy to balance T cell activation and exhaustion, guiding the design of next-generation CAR-T therapies.